Phase Ii Study Of Low-Dose Cyclophosphamide And Ipilimumab In Metastatic Melanoma.

Anna C. Pavlick,Sunandana Chandra,Claire Stein,Kathleen M. Madden,Rajni Kannan,Crystal Escano,Caroline Muren,Ethel Yepes,Rachel Lubong Sabado,Nina Bhardwaj

JOURNAL OF CLINICAL ONCOLOGY（2014）

引用 4|浏览24

暂无评分

摘要

e20025 Background: Ipilimumab (Ipi) has improved clinical outcomes in metastatic melanoma (MM). Previous data suggested that low doses of cyclophosphamide (ldCTX) may have immunomodulatory effects ...

查看译文

关键词

metastatic melanoma,ipilimumab,low-dose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要